CYP2D6 HhaI Genotype and the Neuroleptic Malignant Syndrome

Publisher： Karger

E-ISSN： 1423-0224|39|1|33-37

ISSN： 0302-282x

Source： Neuropsychobiology, Vol.39, Iss.1, 1999-01, pp. : 33-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CYP2D6 Genotype Predicts Antipsychotic Side Effects in Schizophrenia Inpatients: A Retrospective Matched Case-Control Study

By  

Neuropsychobiology, Vol. 59, Iss. 4, 2009-06 ,pp. : 222-226

Karger

Access to resources Recommend Favorite

Whole Deletion of CYP2A6 Gene (CYP2A6*4C) and Smoking Behavior

By  

Neuropsychobiology, Vol. 49, Iss. 2, 2004-02 ,pp. : 101-104

Karger

Access to resources Recommend Favorite

Relationship between Alcoholism and CYP2E1 C/D Polymorphism

By  

Neuropsychobiology, Vol. 38, Iss. 4, 1998-11 ,pp. : 218-221

Karger

Access to resources Recommend Favorite

CYP2E1 and Clinical Features in Alcoholics

By  

Neuropsychobiology, Vol. 47, Iss. 2, 2003-04 ,pp. : 86-89

Karger

Access to resources Recommend Favorite

Association Study between Antipsychotics- Induced Restless Legs Syndrome and Polymorphisms of Dopamine D1, D2, D3, and D4 Receptor Genes in Schizophrenia

By  

Neuropsychobiology, Vol. 57, Iss. 1-2, 2008-05 ,pp. : 49-54

Karger

Access to resources Recommend Favorite